151 related articles for article (PubMed ID: 38162610)
1. Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia's invasion of Ukraine in five major cities in Ukraine.
Mazhnaya A; Meteliuk A; Pykalo I; Altice FL
Front Public Health; 2023; 11():1238188. PubMed ID: 38162610
[TBL] [Abstract][Full Text] [Related]
2. Treatment of opioid use disorder in Ukraine during the first year of the Russia-Ukraine war: Lessons learned from the crisis.
Morozova O; Ivanchuk I; Gvozdetska O; Nesterova O; Skala P; Kuzin I; Dumchev K
Int J Drug Policy; 2023 Jul; 117():104062. PubMed ID: 37216758
[TBL] [Abstract][Full Text] [Related]
3. Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west.
Ivasiy R; Galvez de Leon SJ; Meteliuk A; Fomenko T; Pykalo I; Bromberg DJ; Madden LM; Farnum SO; Islam Z; Altice FL
Front Public Health; 2022; 10():1044677. PubMed ID: 36711398
[No Abstract] [Full Text] [Related]
4. Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.
Dubov A; Basenko A; Dymaretskyi O; Shoptaw S
Drug Alcohol Depend; 2024 Feb; 255():111069. PubMed ID: 38159338
[TBL] [Abstract][Full Text] [Related]
5. Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study.
Poulsen MN; Roe SA; Asdell PB; Rahm AK; Berrettini W
J Subst Use Addict Treat; 2024 Mar; 158():209250. PubMed ID: 38072381
[TBL] [Abstract][Full Text] [Related]
6. Introducing methadone maintenance therapy into Ukrainian prisons: a qualitative study of criminal subculture, Russia's full-scale invasion, and contested methadone objects.
Ponticiello M; Azbel L; Tate MM; Bromberg DJ; Pykalo I; Kiriazova T; Saichuk N; Altice FL
Front Psychiatry; 2023; 14():1227216. PubMed ID: 38098632
[TBL] [Abstract][Full Text] [Related]
7. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.
Saunders EC; Moore SK; Walsh O; Metcalf SA; Budney AJ; Scherer E; Marsch LA
J Subst Abuse Treat; 2020 Apr; 111():54-66. PubMed ID: 32076361
[TBL] [Abstract][Full Text] [Related]
8. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
Dellamura P; Meteliuk A; Fomenko T; Rozanova J
Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
[TBL] [Abstract][Full Text] [Related]
9. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Schiff DM; Work EC; Muftu S; Partridge S; MacMillan KDL; Gray JR; Hoeppner BB; Kelly JF; Greenfield SF; Jones HE; Wilens TE; Terplan M; Bernstein J
J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614
[TBL] [Abstract][Full Text] [Related]
10. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
[TBL] [Abstract][Full Text] [Related]
11. Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities.
Walters SM; Perlman DC; Guarino H; Mateu-Gelabert P; Frank D
Subst Use Misuse; 2022; 57(7):1144-1153. PubMed ID: 35443862
[No Abstract] [Full Text] [Related]
12. Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians.
Wheeler PB; Miller-Roenigk B; Jester J; Stevens-Watkins D
Ann Med; 2024 Dec; 56(1):2322051. PubMed ID: 38442301
[TBL] [Abstract][Full Text] [Related]
13. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
[TBL] [Abstract][Full Text] [Related]
14. Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates.
Paul N; Kennedy AJ; Taubenberger S; Chang JC; Hacker K
Subst Abus; 2022; 43(1):742-748. PubMed ID: 35100094
[TBL] [Abstract][Full Text] [Related]
15. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.
Ahmed OM; Mao JA; Holt SR; Hawk K; D'Onofrio G; Martel S; Melnick ER
J Subst Abuse Treat; 2019 Jul; 102():47-52. PubMed ID: 31202288
[TBL] [Abstract][Full Text] [Related]
16. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
Gustavson AM; Kenny ME; Wisdom JP; Salameh HA; Ackland PE; Gordon AJ; Hagedorn HJ
Addict Sci Clin Pract; 2021 Aug; 16(1):51. PubMed ID: 34362445
[TBL] [Abstract][Full Text] [Related]
17. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
[No Abstract] [Full Text] [Related]
18. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
19. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
[No Abstract] [Full Text] [Related]
20. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
Matsumoto A; Santelices C; Evans EA; Pivovarova E; Stopka TJ; Ferguson WJ; Friedmann PD
Int J Drug Policy; 2022 Nov; 109():103823. PubMed ID: 35994938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
